125th MAINE LEGISLATURE
		LD 1840		LR 2680(02)
	An Act To Limit MaineCare Reimbursement for Methadone Treatment
	Fiscal Note for Bill as Amended by Committee Amendment "   "
	Committee: Health and Human Services
	Fiscal Note Required: Yes
Fiscal Note
			FY 2011-12	FY 2012-13	Projections  FY 2013-14	Projections  FY 2014-15
Net Cost (Savings)
	General Fund		$0	($1,364,117)	($2,728,232)	($2,728,232)
Appropriations/Allocations
	General Fund		$0	($1,364,117)	($2,728,232)	($2,728,232)
	Federal Expenditures Fund		$0	($2,297,941)	($4,595,882)	($4,595,882)
Revenue
	Federal Expenditures Fund		$0	($2,297,941)	($4,595,882)	($4,595,882)
Fiscal Detail and Notes
	The General Fund savings associated with limiting MaineCare reimbursement for methadone for the treatment of addiction to opioids to a lifetime maximum of 24 months with prior authorization beyond 24 months is estimated to be $1,364,117 in fiscal year 2012-13.  The Federal Expenditures Fund share of the savings is estimated to be $2,297,941 in fiscal year 2012-13.